CardieX Past Earnings Performance

Past criteria checks 0/6

CardieX's earnings have been declining at an average annual rate of -37.2%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 13.9% per year.

Key information

-37.2%

Earnings growth rate

-19.8%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate13.9%
Return on equity-43,329.9%
Net Margin-66.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

What Can We Learn About CardieX's (ASX:CDX) CEO Compensation?

Feb 16
What Can We Learn About CardieX's (ASX:CDX) CEO Compensation?

Shareholders Are Thrilled That The CardieX (ASX:CDX) Share Price Increased 169%

Jan 12
Shareholders Are Thrilled That The CardieX (ASX:CDX) Share Price Increased 169%

Have Insiders Been Buying CardieX Limited (ASX:CDX) Shares?

Dec 07
Have Insiders Been Buying CardieX Limited (ASX:CDX) Shares?

Revenue & Expenses Breakdown
Beta

How CardieX makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:CDX Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2314-9153
30 Sep 2310-14164
30 Jun 236-19164
31 Mar 235-16164
31 Dec 224-14153
30 Sep 224-13143
30 Jun 225-12132
31 Mar 225-11113
31 Dec 215-10112
30 Sep 215-7101
30 Jun 216-572
31 Mar 215-481
31 Dec 205-371
30 Sep 205-371
30 Jun 205-371
31 Mar 205-380
31 Dec 195-480
30 Sep 195-370
30 Jun 195-370
31 Mar 195-361
31 Dec 184-362
30 Sep 184-362
30 Jun 184-352
31 Mar 185-351
31 Dec 175-451
30 Sep 175-461
30 Jun 175-461
31 Mar 175-472
31 Dec 165-482
30 Sep 165-582
30 Jun 165-582
31 Mar 165-472
31 Dec 154-472
30 Sep 155-362
30 Jun 155-162
31 Mar 155-262
31 Dec 145-261
30 Sep 145-261
30 Jun 145-361
31 Mar 146-261
31 Dec 136061
30 Sep 138161
30 Jun 139351

Quality Earnings: CDX is currently unprofitable.

Growing Profit Margin: CDX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CDX is unprofitable, and losses have increased over the past 5 years at a rate of 37.2% per year.

Accelerating Growth: Unable to compare CDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: CDX has a negative Return on Equity (-43329.88%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.